Secondary Hemostasis (Coagulation Factors)

Primary site of production for most coagulation factors is the

Major site of production for Factor VIII and its vWF portion is

Coagulation factors found to be increased in liver disease are

Coagulation factor characterized by having the shortest half-life of 6 hours is

Laboratory test noted as very good to assess liver function in the acute setting due to early reduction of Factor VII is

Coagulation pathway requiring Factor VII for activation is the

Inheritance pattern common to all coagulation factor deficiencies except Factors VIII and IX is

Inheritance pattern for Factor VIII and Factor IX deficiencies is

Procoagulant identified as the most concentrated among all plasma procoagulants is

Molecular weight, half-life, and mean plasma concentration of Fibrinogen (Factor I) are

Coagulation screening test results expected when fibrinogen level falls below 100 mg/dL are

Role of Fibrinogen in primary hemostasis involves

Molecular weight, half-life, and mean plasma concentration of Prothrombin (Factor II) are

Alternative names for Factor III are

Molecular weight, half-life, and mean plasma concentration of Tissue Factor (Factor III) are

Molecular weight, half-life, and mean plasma concentration of Calcium ions (Factor IV) are

Alternative names for Factor V are

Mutated form of Factor V first described by Dutch investigators from the city of Leiden is

Molecular weight, half-life, and mean plasma concentration of Factor V are

Effect of Protein C-Protein S complex on Factors V and VIII vs Factor V Leiden is

Alternative names for Factor VII are

Molecular weight, half-life, and mean plasma concentration of Factor VII are

Alternative names for Factor VIII are

Molecular weight, half-life, and mean plasma concentration of Factor VIII are

Mechanism of Factor VIII activation during blood coagulation involves

Portion of Factor VIII complex referred to as Factor VIII, Factor VIIIC, or Factor VIII:C is

Portion of Factor VIII complex measured by immunoassays representing antigenic properties is

Portion of Factor VIII complex responsible for platelet aggregation in the presence of ristocetin is

Antigenic portion of the von Willebrand factor measured by immunoassays is

Molecular weight, half-life, and mean plasma concentration of von Willebrand Factor (vWF) are

Receptor site binding capabilities of von Willebrand Factor (vWF) include

Primary platelet surface receptor for von Willebrand Factor (vWF) is

Alternative names for Factor IX are

Molecular weight, half-life, and mean plasma concentration of Factor IX are

Alternative name for Factor X is

Molecular weight, half-life, and mean plasma concentration of Factor X are

Alternative names for Factor XI are

Molecular weight, half-life, and mean plasma concentration of Factor XI are

Alternative names for Factor XII are

Clinical bleeding tendency vs thrombotic risk associated with Factor XII deficiency is

Molecular weight, half-life, and mean plasma concentration of Factor XII are

Alternative names for Factor XIII are

Laboratory screening test utilized to detect Factor XIII deficiency is

Molecular weight, half-life, and mean plasma concentration of Factor XIII are

Alternative name for Prekallikrein (PK) is

Molecular weight, half-life, and mean plasma concentration of Prekallikrein (PK) are

Alternative names for High-molecular-weight Kininogen (HMWK) are

Molecular weight, half-life, and mean plasma concentration of HMWK are

Platelet phospholipid substance considered a key coagulation factor (formerly Platelet Factor 3 or PF-3) is

Definition of zymogens in the coagulation cascade refers to

Eight coagulation factors that circulate as zymogens include

Coagulation factors that function as cofactors include

Factors comprising the Intrinsic Coagulation Pathway are

Factors comprising the Extrinsic Coagulation Pathway are

Factors comprising the Common Coagulation Pathway are

Factors comprising the Fibrinogen Group are

Factors comprising the Prothrombin Group are

Factors comprising the Contact Group are

Presence of Fibrinogen Group factors in serum vs plasma is

Vitamin K and Calcium dependency of Fibrinogen Group factors are

Presence of Prothrombin Group factors in aged serum is

Vitamin K and Calcium dependency of Prothrombin Group factors are

Adsorbing agents used to remove Prothrombin Group factors from plasma are

Vitamin K and Calcium dependency of Contact Group factors are

Definition of PIVKA (Protein Induced by Vitamin K Absence) is

Application of the traditional coagulation cascade concept is

Coagulation factors activated directly by Thrombin are

Components comprising the Tenase Complex are

Components comprising the Prothrombinase Complex are

Phase of coagulation in which Calcium is NOT involved is

Solubility characteristic of a stabilized fibrin clot in 5M Urea is

Two essential cell types required for in vivo (physiologic) cell-based coagulation complexes are

Two main phases describing in vivo coagulation are

Site of occurrence and thrombin yield during the INITIATION phase of in vivo coagulation are

Site of occurrence and thrombin yield during the PROPAGATION phase of in vivo coagulation are

Primary triggering complex that initiates in vivo coagulation on tissue factor-bearing cells is

Complexes that assemble on activated platelet membranes during the propagation phase to produce a burst of thrombin are